These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 3889629)
1. Fate of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in Sprague-Dawley rats. I. Mutagens in the urine. Barnes WS; Weisburger JH Mutat Res; 1985; 156(1-2):83-91. PubMed ID: 3889629 [TBL] [Abstract][Full Text] [Related]
2. Identification of the cooked food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and its N-acetylated and 3-N-demethylated metabolites in rat urine. Peleran JC; Rao D; Bories GF Toxicology; 1987 Feb; 43(2):193-9. PubMed ID: 3810661 [TBL] [Abstract][Full Text] [Related]
3. Mutagenic activity of three synthetic isomers of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in the Ames test. Vikse R; Klungsøyr L; Grivas S Mutat Res; 1993 Dec; 319(4):273-8. PubMed ID: 7504200 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ. Morrison LD; Eling TE; Josephy PD Mutat Res; 1993 May; 302(1):45-52. PubMed ID: 7683106 [TBL] [Abstract][Full Text] [Related]
5. Modulation of the mutagenic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in bacteria with rat-liver 9000 x g supernatant or monolayers of rat hepatocytes as an activation system. Holme JA; Brunborg G; Alexander J; Trygg B; Bjørnstad C Mutat Res; 1988 Jan; 197(1):39-49. PubMed ID: 3275882 [TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of the food mutagen 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and analogs. Barnes WS; Lovelette CA; Tong C; Williams GM; Weisburger JH Carcinogenesis; 1985 Mar; 6(3):441-4. PubMed ID: 3884172 [TBL] [Abstract][Full Text] [Related]
8. Chemical structure and mutagenic activity of aminoimidazoquinolines and aminonaphthimidazoles related to 2-amino-3-methylimidazo[4,5-f]quinoline. Kaiser G; Harnasch D; King MT; Wild D Chem Biol Interact; 1986 Jan; 57(1):97-106. PubMed ID: 3512112 [TBL] [Abstract][Full Text] [Related]
9. Chlorophyllin-enhanced excretion of urinary and fecal mutagens in rats given 2-amino-3-methylimidazo[4,5-f]quinoline. Dashwood R; Liew C Environ Mol Mutagen; 1992; 20(3):199-205. PubMed ID: 1396610 [TBL] [Abstract][Full Text] [Related]
10. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ). Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317 [TBL] [Abstract][Full Text] [Related]
11. Effect of tryptamine on the mutagenic activity of 2-amino-3-methylimidazo(4,5-f) quinoline (IQ) and related azaarenes in the Ames test. Abu-Shakra A; Ioannides C; Walker R Mutagenesis; 1987 Jan; 2(1):51-6. PubMed ID: 3331694 [TBL] [Abstract][Full Text] [Related]
12. Effect of methyl substitution on mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline, isolated from broiled sardine. Nagao M; Wakabayashi K; Kasai H; Nishimura S; Sugimura T Carcinogenesis; 1981; 2(11):1147-9. PubMed ID: 7032742 [TBL] [Abstract][Full Text] [Related]
13. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species. Alldrick AJ; Rowland IR Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay. Snyderwine EG; Welti DH; Fay LB; Würzner HP; Turesky RJ Chem Res Toxicol; 1992; 5(6):843-51. PubMed ID: 1489936 [TBL] [Abstract][Full Text] [Related]
15. Differential mutagenic activity of IQ (2-amino-3-methylimidazo[4,5-f]quinoline) in Salmonella typhimurium strains in vitro and in vivo, in Drosophila, and in mice. Wild D; Gocke E; Harnasch D; Kaiser G; King MT Mutat Res; 1985; 156(1-2):93-102. PubMed ID: 3923347 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline in the male rat. Inamasu T; Luks H; Vavrek MT; Weisburger JH Food Chem Toxicol; 1989 Jun; 27(6):369-76. PubMed ID: 2792966 [TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences. Abu-Shakra A; Ioannides C; Walker R Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675 [TBL] [Abstract][Full Text] [Related]
18. Impact of aqueous doash extract on urinary mutagenicity in rats exposed to heterocyclic amines. Khan JA; Jalal JA; Ioanndes C; Moselhy SS Toxicol Ind Health; 2013 Mar; 29(2):142-8. PubMed ID: 22173956 [TBL] [Abstract][Full Text] [Related]
19. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study. Edenharder R; Rauscher R; Platt KL Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the mutagen 2-amino-3-methylimidazo[4,5-f]quinoline prepared from a 2-methylpyridine/creatinine/acetylformaldehyde model system. Lee H; Lin MY; Lin ST Mutagenesis; 1994 Mar; 9(2):157-62. PubMed ID: 8201949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]